Harnessing synthetic biology for advancing RNA therapeutics and vaccine design.

ABSTRACT: Recent global events have drawn into focus the diversity of options for combatting disease across a spectrum of prophylactic and therapeutic approaches. The recent success of the mRNA-based COVID-19 vaccines has paved the way for RNA-based treatments to revolutionize the pharmaceutical industry. However, historical treatment options are continuously updated and reimagined in the context of novel technical developments, such as those facilitated through the application of synthetic biology. When it comes to the development of genetic forms of therapies and vaccines, synthetic biology offers diverse tools and approaches to influence the content, dosage, and breadth of treatment with the prospect of economic advantage provided in time and cost benefits. This can be achieved by utilizing the b

SUBMITTER: Pfeifer BA 

PROVIDER: S-EPMC10689799 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature